Insufficient Funds Hinders TB Vaccine Development
ADVERTISEMENT According to an article published in Aljazeera, health officials, and activists are calling for increased investment in developing new vaccines to tackle the surge in tuberculosis (TB), fueled by COVID-19 and conflicts, including in Ukraine and Sudan. At a meeting of top United Nations health leaders on Monday at the UN headquarters in New […]
New Fungal Infection Discovered In The U.S.
ADVERTISEMENT A recent report from the Centers for Disease Control and Prevention (CDC) has detailed the emergence of a novel dermatophyte species causing severe, antifungal-resistant tinea infections. The species, called Trichophyton indotineae, has caused an epidemic of infections in South Asia due to the misuse and overuse of topical antifungals and corticosteroids. These infections are […]
Desulfovibrio Bacteria Identified As Potential Cause Of Parkinson’s Disease
ADVERTISEMENT Researchers at the University of Helsinki have made a significant breakthrough in identifying the cause of Parkinson’s disease. According to their recently published study, specific strains of Desulfovibrio bacteria are likely to cause the disease in most cases. The study enables the screening of carriers of these harmful bacteria, allowing for their removal from […]
FDA Approves the First RSV Vaccine for Adults Over 60
ADVERTISEMENT The U.S. Food and Drug Administration (FDA) has approved the first respiratory syncytial virus (RSV) vaccine, named Arexvy, for individuals aged 60 years and older. The FDA’s approval of the respiratory syncytial virus vaccine is a tremendous step for public health. It demonstrates how seriously the FDA supports the development of safe and effective […]
Sloth Fur Yields Potential Antibiotic Compounds for Human Medicine
ADVERTISEMENT Antibiotic-resistant “superbugs” have emerged as a significant global health issue. On the other hand, a discovery by researchers at the University of Costa Rica gives us reason to be optimistic about our ability to tackle these deadly diseases. Antibiotic-producing bacteria have been discovered in the fur of Costa Rican sloths, which could lead to […]
Mutating Dog Flu Virus Sparks Concern for Possible Human Transmission
ADVERTISEMENT In recent years, a type of influenza virus known as H3N2 has been spreading among dogs, leading to a condition commonly referred to as “dog flu.” While the virus has primarily remained confined to the canine population, a new study from China suggests that it may evolve and adapt to better recognize human-like receptors. […]
Russian Soldiers in Ukraine Infected with Anthrax: Concerns Raised Over Biological Warfare
ADVERTISEMENT The discovery of anthrax in a Russian trench line in southern Ukraine has raised concerns about the potential use of biological weapons in the ongoing conflict between Ukraine and Russia. While it was reported that the soldiers had contracted the bacterial infection from an unearthed burial site for cattle, the history of anthrax as […]
Century-Old TB Vaccine Ineffective Against COVID-19
ADVERTISEMENT In the early days of the Covid-19 pandemic, when effective treatments and vaccines were still a distant hope, scientists began testing an old tuberculosis vaccine, known as B.C.G., against the coronavirus. The hope was that this vaccine, developed in the early 1900s to combat T.B. and was known to bolster the immune system, might […]
From COVID-19 to the Next Pandemic: WHO’s PRET Initiative to Ensure Global Readiness
ADVERTISEMENT The World Health Organization (WHO) has launched the Preparedness and Resilience for Emerging Threats Initiative (PRET) to provide guidance on integrated planning for responding to respiratory pathogens such as coronaviruses and influenza. Given the common capacities and capabilities among groups of pathogens, this initiative uses a mode of transmission approach to guide countries in […]
Revolutionary Vowst Marks a Significant Milestone in CDI Prevention
ADVERTISEMENT The U.S. Food and Drug Administration (FDA) has approved Vowst, the first oral-fecal microbiota product, to prevent the recurrence of Clostridioides difficile (C. difficile) infection in patients over the age of 18, following antibacterial treatment for recurrent CDI. This is a significant step forward in advancing patient care and accessibility, according to Peter Marks, […]
